Both liraglutide and exenatide showed significant decreases in liver fat, liver enzymes, and fibrosis index associated with metabolically associated steatotic liver disease (MASLD) [130]
In vivo preclinical models exploring dermal repair, antifibrotic effects, neuroprotection, and pain modulation through pathways involving VEGF, TGF, miRregulated signaling, and amino acidmediated analgesia
These observations, derived from various studies and case reports, emphasize the critical need for healthcare providers to be vigilant about potential drug interactions when prescribing orlistat, especially for patients on concurrent medications that might be impacted by altered lipid absorption dynamics
doi:10.1016/j.phymed.2014.04.026 Al-Maweri SA, Kalakonda B, AlAizari NA, et al